Syndax Pharmaceuticals shares owned by T. Rowe Price Associates
Quarter-by-quarter ownership of Syndax Pharmaceuticals (SNDX) shares owned by T. Rowe Price Associates
from 13F filings
Historical chart of T. Rowe Price Associates investment in Syndax Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Syndax Pharmaceuticals held by T. Rowe Price Associates consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Syndax Pharmaceuticals by T. Rowe Price Associates
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-03-31 | $2.5M | 107k | 23.36 |
| 2025-12-31 | $2.0M | 95k | 21.02 |
| 2025-09-30 | $1.4M | 91k | 15.38 |
| 2025-06-30 | $706k | 75k | 9.36 |
| 2025-03-31 | $813k | 66k | 12.30 |
| 2024-12-31 | $754k | 57k | 13.22 |
| 2024-09-30 | $942k | 49k | 19.25 |
| 2024-06-30 | $990k | 48k | 20.54 |
| 2024-03-31 | $1.1M | 45k | 23.81 |
| 2023-12-31 | $568k | 26k | 21.62 |
| 2023-09-30 | $355k | 24k | 14.54 |
| 2023-06-30 | $481k | 23k | 20.97 |
| 2023-03-31 | $241k | 11k | 21.21 |
| 2022-12-31 | $238k | 9.4k | 25.42 |
| 2021-09-30 | $9.9M | 516k | 19.11 |
| 2021-06-30 | $7.2M | 420k | 17.17 |
| 2021-03-31 | $9.8M | 439k | 22.36 |
| 2020-12-31 | $3.8M | 171k | 22.24 |